Abstract
Posthypoxic and postencephalitic myoclonus is often poorly controlled with current treatments. The authors successfully treated three patients with posthypoxic and postencephalitic myoclonus by using levetiracetam, a new antiepileptic drug. Levetiracetam appears to be a promising agent for treating action myoclonus caused by hypoxic and encephalitic brain injury - the degree of functional improvement may depend on the severity of associated motor dysfunction.
Original language | English (US) |
---|---|
Pages (from-to) | 411-412 |
Number of pages | 2 |
Journal | Neurology |
Volume | 56 |
Issue number | 3 |
DOIs | |
State | Published - Feb 13 2001 |
ASJC Scopus subject areas
- Clinical Neurology